High-Intensity Interval Training for Lupus

(MIGHT-SLE Trial)

Not yet recruiting at 1 trial location
JE
VK
LJ
Overseen ByLeslie Johnson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Systemic lupus erythematosus, or SLE, is a chronic autoimmune disease that can cause persistent fatigue, muscle pain, reduced physical function, and impaired quality of life, even when the disease is otherwise clinically stable. The biological mechanisms contributing to these symptoms are not fully understood. Abnormal energy production within skeletal muscle and increased fat accumulation within the muscle may contribute to fatigue and reduced physical performance in people with SLE.

This pilot study will evaluate the effects of a 16-week personalized, home-based exercise program in 20 adults with stable SLE and clinically significant fatigue. The program will include three exercise sessions per week: bodyweight high-intensity interval training, strength training, and walking-based interval training. Sessions will be adapted to each participant's fitness, mobility, symptoms, and exercise tolerance. Some sessions will be supervised remotely by video, while others will be completed independently using personalized recorded instructions.

Participants will undergo assessments before and after the 16-week program. These assessments will examine skeletal muscle mitochondrial function, fat accumulation within the thigh muscles, physical performance, fatigue, quality of life, and blood-based markers of mitochondrial function and inflammation.

The study will help determine whether a personalized home-based exercise program can improve muscle health and physical function in people with SLE and will provide information needed to design larger future studies.

Who Is on the Research Team?

JE

Jose E Rubio, MD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 with stable lupus (SLE) who have ongoing fatigue or muscle pain. Participants must be able to safely exercise at home, have no severe organ involvement, and be on stable lupus medications. People with serious heart, kidney, or lung problems, recent major illness or surgery, pregnancy, or those already in an exercise program cannot join.

Inclusion Criteria

Able and willing to comply with the home-based exercise protocol and study procedures
My lupus is stable, not affecting my kidneys or brain, and my disease activity is low.
Able and willing to provide informed consent
See 6 more

Exclusion Criteria

Severe anemia with hemoglobin less than 10 g/dL
My lupus is currently very active and severe.
Pregnancy
See 19 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a 16-week personalized, home-based exercise program with three sessions per week, including bodyweight high-intensity interval training, strength training, and walking-based interval training.

16 weeks
Sessions alternate between remotely supervised video sessions and self-directed sessions

Follow-up

Participants are monitored for changes in skeletal muscle mitochondrial function, intermuscular adipose tissue, physical performance, fatigue, and quality of life after the intervention.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Personalized Home-Based High-Intensity Interval Training

Trial Overview

The study tests a personalized home-based high-intensity interval training program over 16 weeks for people with SLE and fatigue. The program includes three weekly sessions of bodyweight exercises, strength training, and walking intervals—some supervised by video and some done independently.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Personalized Home-Based HIITExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Lupus Research Alliance

Collaborator

Trials
6
Recruited
3,900+